DHTPY-Cu@ZOL-Enhanced Photodynamic Therapy: A Strategic Platform for Advanced Treatment of Drug-Resistant Bacterial Wound Infections
Open Access
- 1 June 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 6319-6336
Abstract
Purpose: This research was to innovate a nanozyme-based therapeutic strategy that combines aggregation-induced emission (AIE) photosensitizers with copper nanozymes. This approach is designed to address the hypoxic conditions often found in bacterial infections and aims to boost the effectiveness of photodynamic therapy (PDT) by ensuring sufficient oxygen supply for reactive oxygen species (ROS) generation. Methods: Our approach involved the synthesis of dihydroxyl triphenyl vinyl pyridine (DHTPY)-Cu@zoledronic acid (ZOL) nanozyme particles. We initially synthesized DHTPY and then combined it with copper nanozymes to form the DHTPY-Cu@ZOL composite. The nanozyme’s size, morphology, and chemical properties were characterized using various techniques, including dynamic light scattering, transmission electron microscopy, and X-ray photoelectron spectroscopy. We conducted a series of in vitro and in vivo tests to evaluate the photodynamic, antibacterial, and wound-healing properties of the DHTPY-Cu@ZOL nanozymes, including their oxygen-generation capacity, ROS production, and antibacterial efficacy against methicillin-resistant Staphylococcus aureus (MRSA). Results: The DHTPY-Cu@ZOL exhibited proficient H2O2 scavenging and oxygen generation, crucial for enhancing PDT in oxygen-deprived infection environments. Our in vitro analysis revealed a notable antibacterial effect against MRSA, suggesting the nanozymes’ potential to disrupt bacterial cell membranes. Further, in vivo studies using a diabetic rat model with MRSA-infected wounds showed that DHTPY-Cu@ZOL markedly improved wound healing and reduced bacterial presence, underscoring its efficacy as a non-antibiotic approach for chronic infections. Conclusion: Our study suggests that DHTPY-Cu@ZOL is a highly promising approach for combating antibiotic-resistant microbial pathogens and biofilms. The biocompatibility and stability of these nanozyme particles, coupled with their improved PDT efficacy position them as a promising candidate for clinical applications.Keywords
This publication has 40 references indexed in Scilit:
- Recent Development of Copper‐Based Nanozymes for Biomedical ApplicationsAdvanced Healthcare Materials, 2023
- A Whole‐Course‐Repair System Based on Neurogenesis‐Angiogenesis Crosstalk and Macrophage Reprogramming Promotes Diabetic Wound HealingAdvanced Materials, 2023
- Nanozymes for Regenerative MedicineSmall Methods, 2022
- Wound microenvironment self-adaptive hydrogel with efficient angiogenesis for promoting diabetic wound healingBioactive Materials, 2022
- An Electroluminodynamic Flexible Device for Highly Efficient Eradication of Drug‐Resistant BacteriaAdvanced Materials, 2022
- Type I Photosensitizers Revitalizing Photodynamic OncotherapySmall, 2021
- Bioinspired Spiky Peroxidase‐Mimics for Localized Bacterial Capture and Synergistic Catalytic SterilizationAdvanced Materials, 2021
- Near‐Infrared AIE Dots with Chemiluminescence for Deep‐Tissue ImagingAdvanced Materials, 2020
- Cu2MoS4/Au Heterostructures with Enhanced Catalase‐Like Activity and Photoconversion Efficiency for Primary/Metastatic Tumors Eradication by Phototherapy‐Induced ImmunotherapySmall, 2020
- Rejuvenated Photodynamic Therapy for Bacterial InfectionsAdvanced Healthcare Materials, 2019